Want to join the conversation?
$WFM said that its strategy is to adjust its operating model through lower margin & lower cost structure. The company had earlier announced its goal to reduce its cost structure by $300MM run rate by FY17. Though $WFM has some headwinds to overcome in the form of lower sales & higher healthcare costs, this larger goal of reducing cost remains same.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?